Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 327 results for "lymphocyte count"

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market -...

Forecast & Market Forecast in G8 Countries) (2011 - 2020) 04/03 11:43 CDT Forecast & Market Forecast in G8 Countries) (2011 - 2020) LONDON, April 3, 2014 LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market ... Finwin, 2 weeks ago

1 images for "lymphocyte count"

Glia, 3 months ago

Is Absolute Lymphocyte Count a Good Prognostic Predictor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation?

Remember me What does "Remember me" mean? By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your ...
 Transplantation1 month ago Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation  Transplantation1 month ago

Vemurafenib decreased lymphocyte counts, altered T-cells in melanoma

Vemurafenib and dabrafenib demonstrated similar efficacy in patients with melanoma, but only vemurafenib treatment was associated with decreased peripheral lymphocyte counts and altered CD4-positive T-cell phenotype and function, according to study ...
 Orthopedics Today1 month ago

Lymphocytic Pleural Effusion and Change of the Adenosine Deaminase Cut-Off Level in Tuberculosis Diagnosis

SESSION TITLE: Pleural Disease/Pleural Effusion Posters SESSION TYPE: Poster Presentations PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM PURPOSE: To assess the discriminatory power of pleural ADA levels in pleural effusions ...
 CHEST1 month ago

Cancers in HIV/AIDS: Epidemiology, Therapeutic Challenges

Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:12041210. Schneider E, Whitmore S, Glynn KM, ...
 Medscape1 month ago

Erratum: Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

Correction N Engl J Med 2014; 370:786 February 20, 2014 DOI: 10.1056/NEJMx140003 Article Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia ( Original Article, N Engl J Med 2013 ; 369 : 32 - 42 ) . In the ...
 New England Journal of Medicine1 month ago
MedIndia

The number of tumor cells spread to sentinel lymph nodes affects melanoma prognosis

PUBLIC RELEASE DATE: 18-Feb-2014 Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death. According to a study published in this week's ...
 EurekAlert!1 month ago Melanoma prognosis affected by number of tumor cells spread to sentinel lymph nodes  Medical News Today1 month ago Melanoma Prognosis Determined by Tumor Cells Spreading to Sentinel Lymph Nodes  MedIndia1 month ago

GSK and Genmab receive FDA approval for Arzerra(r) (ofatumumab) as first-line

treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate treatment in combination with chlorambucil for patients with Chronic Lymphocytic ...
 Finwin14 hours ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate  4 Traders1 hour ago 4/17/14 - GSK and Genmab Receive FDA Approval for Arzerra® (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate  Pharmacy Choice9 hours ago GENMAB A/S : GSK and Genmab Receive FDA Approval for Arzerra(r) (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate  4 Traders16 hours ago
[x]  

"Methods for Treatment of Lymphomas with Mutations in Cell Cycle Genes" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Life Science Weekly -- A patent application by the inventors WENDEL , Hans Guido ( New York, NY ); Oricchio, Elisa ( New York, NY ), filed on March 14, 2013 , was made available online on March 27, 2014 , ...
 4 Traders2 weeks ago New Findings on Sepsis Described by Investigators at Technical University  NewsRX7 hours ago Patent Issued for Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes  HispanicBusiness.com1 day ago Researchers at University of Washington Report Findings in Graft-Versus-Host Disease  HispanicBusiness.com1 day ago

Investigating the patient with a raised white cell count

Clinical investigations from the RACP Michael Harvey Abstract To identify the cause of an elevated white cell count, a careful examination should be performed, a detailed history taken and a blood ...
 Medicine Today2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less